DOXORUBICIN

Clinical trials for DOXORUBICIN explained in plain language.

Never miss a new study

Get alerted when new DOXORUBICIN trials appear

Sign up with your email to follow new studies for DOXORUBICIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Immunotherapy combo shows promise in bladder cancer trial

Disease control Recruiting now

This study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before and after bladder cancer surgery is safe and effective. About 150 people with muscle-invasive bladder cancer will receive durvalumab plus either ddMVAC or gemcitabine/cisplatin chemo…

Matched conditions: DOXORUBICIN

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

DOXORUBICIN

Get alerted when new DOXORUBICIN trials appear

Immunotherapy combo shows promise in bladder cancer trial